Patents by Inventor Sylvie Bertholet

Sylvie Bertholet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNOGENIC COMPOSITIONS COMPRISING MYCOBACTERIUM TUBERCULOSIS POLYPEPTIDES AND FUSIONS THEREOF
    Publication number: 20240140997
    Abstract: The present invention relates to compositions and fusion proteins containing at least two Mycobacterium sp. antigens, and polynucleotides encoding such compositions and fusion proteins. The invention also relates to methods for their use in the treatment, prevention and/or diagnosis of tuberculosis infections.
    Type: Application
    Filed: January 8, 2024
    Publication date: May 2, 2024
    Inventors: Steven G. REED, Rhea N. COLER, Gregory C. IRETON, Sylvie BERTHOLET
  • Immunogenic compositions comprising polypeptides and fusions thereof
    Patent number: 11897922
    Abstract: The present invention relates to compositions and fusion proteins containing at least two Mycobacterium sp.) antigens, and polynucleotides encoding such compositions and fusion proteins. The invention also relates to methods for their use in the treatment, prevention and/or diagnosis of tuberculosis infections.
    Type: Grant
    Filed: July 6, 2021
    Date of Patent: February 13, 2024
    Assignee: ACCESS TO ADVANCED HEALTH INSTITUTE
    Inventors: Steven G. Reed, Rhea N. Coler, Gregory C. Ireton, Sylvie Bertholet
  • IMMUNOGENIC COMPOSITIONS COMPRISING MYCOBACTERIUM TUBERCULOSIS POLYPEPTIDES AND FUSIONS THEREOF
    Publication number: 20220017578
    Abstract: The present invention relates to compositions and fusion proteins containing at least two Mycobacterium sr) antigens, and polynucleotides encoding such compositions and fusion proteins, The invention also relates to methods for their use in the treatment, prevention and/or diagnosis of tuberculosis infections.
    Type: Application
    Filed: July 6, 2021
    Publication date: January 20, 2022
    Inventors: Steven G. REED, Rhea N. COLER, Gregory C. IRETON, Sylvie BERTHOLET
  • IMMUNOGENIC COMPOSITIONS AND USES THEREOF
    Publication number: 20210252133
    Abstract: The present invention is in the field of treating and/or preventing viral infections. In particular, the present invention relates to immunogenic or pharmaceutical compositions comprising self-replicating RNA molecules that encode influenza virus antigens for treating and/or preventing influenza infections.
    Type: Application
    Filed: August 16, 2019
    Publication date: August 19, 2021
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Sylvie BERTHOLET GIRARDIN, Arun KUMAR
  • Immunogenic compositions comprising polypeptides and fusions thereof
    Patent number: 11091521
    Abstract: The present invention relates to compositions and fusion proteins containing at least two Mycobacterium sp. antigens, and polynucleotides encoding such compositions and fusion proteins. The invention also relates to methods for their use in the treatment, prevention and/or diagnosis of tuberculosis infections.
    Type: Grant
    Filed: November 16, 2017
    Date of Patent: August 17, 2021
    Assignee: Infectious Disease Research Institute
    Inventors: Steven G. Reed, Rhea N. Coler, Gregory C. Ireton, Sylvie Bertholet
  • IMMUNOGENIC COMPOSITIONS COMPRISING MYCOBACTERIUM TUBERCULOSIS POLYPEPTIDES AND FUSIONS THEREOF
    Publication number: 20180170975
    Abstract: The present invention relates to compositions and fusion proteins containing at least two Mycobacterium sp. antigens, and polynucleotides encoding such compositions and fusion proteins. The invention also relates to methods for their use in the treatment, prevention and/or diagnosis of tuberculosis infections.
    Type: Application
    Filed: November 16, 2017
    Publication date: June 21, 2018
    Applicant: Infectious Disease Research Institute
    Inventors: Steven G. REED, Rhea N. COLER, Gregory C. IRETON, Sylvie BERTHOLET
  • Immunogenic compositions comprising polypeptides and fusions thereof
    Patent number: 8486414
    Abstract: The present invention relates to compositions and fusion proteins containing at least two Mycobacterium sp. antigens, and polynucleotides encoding such compositions and fusion proteins. The invention also relates to methods for their use in the treatment, prevention and/or diagnosis of tuberculosis infection.
    Type: Grant
    Filed: April 4, 2008
    Date of Patent: July 16, 2013
    Assignee: Infectious Disease Research Institute
    Inventors: Steven G. Reed, Rhea N. Coler, Gregory C. Ireton, Sylvie Bertholet